The mission of the Preclinical Translational Cancer Research (PTCR) Program is to promote and accelerate scientific discovery and development of ideas through the translational continuum in order to impact the prevention, diagnosis and treatment of cancer, both within the Stephenson Cancer Center's catchment area and nationally. To achieve this goal, the PTCR Program brings together productive and highly-collaborative investigators who organize their research activities into goal-driven, thematically-focused teams.
The PTCR Program Goals are:
Goal 1: To understand the genetic, epigenetic and signaling mechanisms that drive tumor growth, progression and responses to therapy in order to inform the pre-clinical and clinical development of novel cancer therapies.
Thematic Focus: Identifying cancer genes and delineating signaling pathways.
Thematic Focus: Unraveling aberrant epigenetic and transcriptional mechanisms.
Thematic Focus: Understanding metastasis and angiogenesis.